News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,320 Results
Type
Article (2437)
Company Profile (39)
Press Release (35844)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14180)
Career Advice (77)
Deals (2087)
Drug Delivery (9)
Drug Development (4109)
Employer Resources (10)
FDA (432)
Job Trends (764)
News (20218)
Policy (1053)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (146)
Allergies (6)
Alliances (3476)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (433)
Artificial intelligence (10)
Autoimmune disease (3)
Automation (1)
Bankruptcy (11)
Best Places to Work (477)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (18)
Cancer (136)
Cardiovascular disease (4)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (43)
Cervical cancer (2)
Clinical research (3183)
Collaboration (92)
Compensation (47)
COVID-19 (180)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (109)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (465)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4264)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6023)
Executive appointments (93)
FDA (477)
Featured Employer (3)
Funding (77)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (706)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (987)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (3)
Layoffs (36)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (18)
MASH (4)
Medical device (316)
Medtech (316)
Mergers & acquisitions (1167)
Metabolic disorders (33)
Multiple sclerosis (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (89)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (351)
Now hiring (4)
Obesity (15)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (22)
Patient recruitment (4)
Peanut (1)
People (5676)
Pharmaceutical (5)
Phase I (1373)
Phase II (1592)
Phase III (851)
Pipeline (73)
Policy (12)
Postmarket research (31)
Preclinical (591)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (21)
Real estate (422)
Recruiting (5)
Regulatory (804)
Reports (6)
Research institute (147)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (352)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (491)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1698)
Vaccines (28)
Venture capitalists (7)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Today (18)
Last 7 days (53)
Last 30 days (221)
Last 365 days (2567)
2025 (714)
2024 (2616)
2023 (2861)
2022 (3766)
2021 (4061)
2020 (3482)
2019 (2069)
2018 (1571)
2017 (1810)
2016 (1648)
2015 (1855)
2014 (1371)
2013 (1192)
2012 (1398)
2011 (1335)
2010 (1182)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1867)
Australia (299)
California (811)
Canada (134)
China (38)
Colorado (19)
Connecticut (10)
Delaware (3)
Europe (3827)
Florida (43)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (32)
Japan (7)
Kansas (12)
Maryland (24)
Massachusetts (297)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (68)
New York (47)
North Carolina (89)
Northern California (351)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (47)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (352)
Tennessee (2)
Texas (70)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (49)
Wisconsin (6)
38,320 Results for "cogent biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference
March 10, 2025
·
2 min read
Press Releases
Cogent Biosciences to Participate in the Guggenheim Biotech Conference
January 30, 2025
·
1 min read
Press Releases
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
March 25, 2025
·
5 min read
Press Releases
Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
February 27, 2025
·
6 min read
Press Releases
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
·
11 min read
Press Releases
Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting
February 10, 2025
·
2 min read
Business
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the appointment of Cole Pinnow as Chief Commercial Officer.
May 23, 2024
·
6 min read
Press Releases
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
January 14, 2025
·
7 min read
Business
Cogent Biosciences Reports First Quarter 2024 Financial Results
Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, provided a business update and announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
9 min read
1 of 3,832
Next
